{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:53:46Z","timestamp":1794736426332,"version":"4.9.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>B cells have essential functions in multiple sclerosis and in its mouse model, experimental autoimmune encephalomyelitis, both as drivers and suppressors of the disease. The suppressive effects are driven by a regulatory B cell (Breg) population that functions, primarily but not exclusively, via the production of IL-10. However, the mechanisms modulating IL-10-producing Breg abundance are poorly understood. Here we identify SLAMF5 for controlling IL-10<jats:sup>+<\/jats:sup> Breg maintenance and function. In EAE, the deficiency of SLAMF5 in B cells causes accumulation of IL10<jats:sup>+<\/jats:sup> Bregs in the central nervous system and periphery. Blocking SLAMF5 in vitro induces both human and mouse IL-10-producing Breg cells and increases their survival with a concomitant increase of a transcription factor, c-Maf. Finally, in vivo SLAMF5 blocking in EAE elevates IL-10<jats:sup>+<\/jats:sup> Breg levels and ameliorates disease severity. Our results suggest that SLAMF5 is a negative moderator of IL-10<jats:sup>+<\/jats:sup> Breg cells, and may serve as a therapeutic target in MS and other autoimmune diseases.<\/jats:p>","DOI":"10.1038\/s41467-021-22230-z","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T11:06:58Z","timestamp":1616670418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5"],"prefix":"10.1038","volume":"12","author":[{"given":"Lihi","family":"Radomir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0289-5261","authenticated-orcid":false,"given":"Matthias P.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Perpinial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nofar","family":"Schottlender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stav","family":"Rabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9497-6527","authenticated-orcid":false,"given":"Keren","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Lewinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirly","family":"Becker-Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Aharoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Milo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0004-6159","authenticated-orcid":false,"given":"Idit","family":"Shachar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"key":"22230_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Prim. 4, 43 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"22230_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.clim.2008.05.002","volume":"128","author":"CT Harp","year":"2008","unstructured":"Harp, C. T., Lovett-Racke, A. E., Racke, M. K., Frohman, E. M. & Monson, N. L. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis. Clin. Immunol. 128, 382\u2013391 (2008).","journal-title":"Clin. Immunol."},{"key":"22230_CR3","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/brain\/aws105","volume":"135","author":"C Elliott","year":"2012","unstructured":"Elliott, C. et al. Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain 135, 1819\u20131833 (2012).","journal-title":"Brain"},{"key":"22230_CR4","doi-asserted-by":"publisher","first-page":"569827","DOI":"10.3389\/fncel.2020.569827","volume":"14","author":"R Magliozzi","year":"2020","unstructured":"Magliozzi, R. et al. Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients. Front. Cell Neurosci. 14, 569827 (2020).","journal-title":"Front. Cell Neurosci."},{"key":"22230_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/archneur.62.4.574","volume":"62","author":"LM Villar","year":"2005","unstructured":"Villar, L. M. et al. Early differential diagnosis of multiple sclerosis using a new oligoclonal band test. Arch. Neurol. 62, 574\u2013577 (2005).","journal-title":"Arch. Neurol."},{"key":"22230_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00234-011-0841-7","volume":"54","author":"MJ Magraner","year":"2012","unstructured":"Magraner, M. J. et al. Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes. Neuroradiology 54, 5\u201312 (2012).","journal-title":"Neuroradiology"},{"key":"22230_CR7","unstructured":"Alvord, E. C. J., Kies, M. W. & Suckling, A. J. in Progress in Clinical and Biological Research. Vol. 146 (eds Alvord, E. C. Jr., Kies, M. W. & Suckling, A. J.) 1\u2013537 (Allen R. Liss, 1984)."},{"key":"22230_CR8","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1002\/ana.410360714","volume":"36","author":"H Wekerle","year":"1994","unstructured":"Wekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H. & Linington, C. Animal models for multiple sclerosis. Ann. Neurol. 36, S47\u2013S53 (1994).","journal-title":"Ann. Neurol."},{"key":"22230_CR9","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2","volume":"29","author":"JA Lyons","year":"1999","unstructured":"Lyons, J. A., San, M., Happ, M. P. & Cross, A. H. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29, 3432\u20133439 (1999).","journal-title":"Eur. J. Immunol."},{"key":"22230_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/ana.22081","volume":"68","author":"MS Weber","year":"2010","unstructured":"Weber, M. S. et al. B-Cell activation influences t-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann. Neurol. 68, 369\u2013383 (2010).","journal-title":"Ann. Neurol."},{"key":"22230_CR11","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L","volume":"32","author":"JA Lyons","year":"2002","unstructured":"Lyons, J. A., Ramsbottom, M. J. & Cross, A. H. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32, 1905\u20131913 (2002).","journal-title":"Eur. J. Immunol."},{"key":"22230_CR12","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/ijms15021700","volume":"15","author":"V Fernando","year":"2014","unstructured":"Fernando, V. et al. Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice. Int. J. Mol. Sci. 15, 1700\u20131718 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"22230_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-014-0163-1","volume":"2","author":"M Koutrolos","year":"2014","unstructured":"Koutrolos, M., Berer, K., Kawakami, N., Wekerle, H. & Krishnamoorthy, G. Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS. Acta Neuropathol. Commun. 2, 163 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"22230_CR14","doi-asserted-by":"publisher","unstructured":"Vogelaar, C. F. et al. Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation. Sci. Transl. Med. 10, https:\/\/doi.org\/10.1126\/scitranslmed.aao2304 (2018).","DOI":"10.1126\/scitranslmed.aao2304"},{"key":"22230_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3325\/cmj.2019.60.87","volume":"60","author":"R Milo","year":"2019","unstructured":"Milo, R. Therapies for multiple sclerosis targeting B cells. Croat. Med. J. 60, 87\u201398 (2019).","journal-title":"Croat. Med. J."},{"key":"22230_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607\u2013612 (2015).","journal-title":"Immunity"},{"key":"22230_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10875-016-0263-8","volume":"36","author":"A Floudas","year":"2016","unstructured":"Floudas, A., Amu, S. & Fallon, P. G. New insights into IL-10 dependent and IL-10 independent mechanisms of regulatory B cell immune suppression. J. Clin. Immunol. 36, 25\u201333 (2016).","journal-title":"J. Clin. Immunol."},{"key":"22230_CR18","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","volume":"184","author":"SD Wolf","year":"1996","unstructured":"Wolf, S. D., Dittel, B. N., Hardardottir, F. & Janeway, C. A. Jr Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184, 2271\u20132278 (1996).","journal-title":"J. Exp. Med."},{"key":"22230_CR19","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.4049\/jimmunol.1001307","volume":"185","author":"T Matsushita","year":"2010","unstructured":"Matsushita, T., Horikawa, M., Iwata, Y. & Tedder, T. F. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 185, 2240\u20132252 (2010).","journal-title":"J. Immunol."},{"key":"22230_CR20","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","volume":"41","author":"M Matsumoto","year":"2014","unstructured":"Matsumoto, M. et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 41, 1040\u20131051 (2014).","journal-title":"Immunity"},{"key":"22230_CR21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","volume":"3","author":"S Fillatreau","year":"2002","unstructured":"Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. & Anderton, S. M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944\u2013950 (2002).","journal-title":"Nat. Immunol."},{"key":"22230_CR22","first-page":"3420","volume":"118","author":"T Matsushita","year":"2008","unstructured":"Matsushita, T., Yanaba, K., Bouaziz, J. D., Fujimoto, M. & Tedder, T. F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Investig. 118, 3420\u20133430 (2008).","journal-title":"J. Clin. Investig."},{"key":"22230_CR23","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.4049\/jimmunol.1103354","volume":"188","author":"A Ray","year":"2012","unstructured":"Ray, A., Basu, S., Williams, C. B., Salzman, N. H. & Dittel, B. N. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J. Immunol. 188, 3188\u20133198 (2012).","journal-title":"J. Immunol."},{"key":"22230_CR24","doi-asserted-by":"publisher","first-page":"173ra123","DOI":"10.1126\/scitranslmed.3005407","volume":"5","author":"F Flores-Borja","year":"2013","unstructured":"Flores-Borja, F. et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 5, 173ra123 (2013).","journal-title":"Sci. Transl. Med."},{"key":"22230_CR25","doi-asserted-by":"publisher","first-page":"16248","DOI":"10.18632\/oncotarget.24575","volume":"9","author":"G Fouquet","year":"2018","unstructured":"Fouquet, G. et al. Signaling lymphocytic activation molecules Slam and cancers: friends or foes? Oncotarget 9, 16248\u201316262 (2018).","journal-title":"Oncotarget"},{"key":"22230_CR26","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.4049\/jimmunol.167.7.3668","volume":"167","author":"M Martin","year":"2001","unstructured":"Martin, M. et al. CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1. J. Immunol. 167, 3668\u20133676 (2001).","journal-title":"J. Immunol."},{"key":"22230_CR27","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.4049\/jimmunol.174.11.7033","volume":"174","author":"X Romero","year":"2005","unstructured":"Romero, X. et al. CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse. J. Immunol. 174, 7033\u20137042 (2005).","journal-title":"J. Immunol."},{"key":"22230_CR28","doi-asserted-by":"publisher","first-page":"10583","DOI":"10.1073\/pnas.0703893104","volume":"104","author":"QR Yan","year":"2007","unstructured":"Yan, Q. R. et al. Structure of CD84 provides insight into SLAM family function. Proc. Natl Acad. Sci. USA 104, 10583\u201310588 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"22230_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2010.01.010","volume":"32","author":"JL Cannons","year":"2010","unstructured":"Cannons, J. L. et al. Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 32, 253\u2013265 (2010).","journal-title":"Immunity"},{"key":"22230_CR30","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/onc.2016.238","volume":"36","author":"A Marom","year":"2017","unstructured":"Marom, A. et al. CD84 mediates CLL-microenvironment interactions. Oncogene 36, 628\u2013638 (2017).","journal-title":"Oncogene"},{"key":"22230_CR31","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/onc.2013.31","volume":"33","author":"I Binsky-Ehrenreich","year":"2014","unstructured":"Binsky-Ehrenreich, I. et al. CD84 is a survival receptor for CLL cells. Oncogene 33, 1006\u20131016 (2014).","journal-title":"Oncogene"},{"key":"22230_CR32","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1172\/JCI96610","volume":"128","author":"H Lewinsky","year":"2018","unstructured":"Lewinsky, H. et al. CD84 regulates PD-1\/PD-L1 expression and function in chronic lymphocytic leukemia. J. Clin. Invest 128, 5465\u20135478 (2018).","journal-title":"J. Clin. Invest"},{"key":"22230_CR33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1352458518763094","volume":"24","author":"K Gobel","year":"2018","unstructured":"Gobel, K., Ruck, T. & Meuth, S. G. Cytokine signaling in multiple sclerosis: lost in translation. Mult. Scler. 24, 432\u2013439 (2018).","journal-title":"Mult. Scler."},{"key":"22230_CR34","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1586\/eci.13.21","volume":"9","author":"R Aharoni","year":"2013","unstructured":"Aharoni, R. New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis. Expert Rev. Clin. Immunol. 9, 423\u2013440 (2013).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"22230_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbadis.2010.07.008","volume":"1812","author":"EM Chastain","year":"2011","unstructured":"Chastain, E. M., Duncan, D. S., Rodgers, J. M. & Miller, S. D. The role of antigen presenting cells in multiple sclerosis. Biochim Biophys. Acta 1812, 265\u2013274 (2011).","journal-title":"Biochim Biophys. Acta"},{"key":"22230_CR36","doi-asserted-by":"publisher","first-page":"929","DOI":"10.4049\/jimmunol.1302171","volume":"192","author":"ER Pierson","year":"2014","unstructured":"Pierson, E. R., Stromnes, I. M. & Goverman, J. M. B cells promote induction of experimental autoimmune encephalomyelitis by facilitating reactivation of T cells in the central nervous system. J. Immunol. 192, 929\u2013939 (2014).","journal-title":"J. Immunol."},{"key":"22230_CR37","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2741\/3781","volume":"16","author":"B Almolda","year":"2011","unstructured":"Almolda, B., Gonzalez, B. & Castellano, B. Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Front. Biosci. 16, 1157\u20131171 (2011).","journal-title":"Front. Biosci."},{"key":"22230_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","volume":"30","author":"C Mauri","year":"2012","unstructured":"Mauri, C. & Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221\u2013241 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"22230_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/intimm\/dxv038","volume":"27","author":"C Mauri","year":"2015","unstructured":"Mauri, C. & Menon, M. The expanding family of regulatory B cells. Int. Immunol. 27, 479\u2013486 (2015).","journal-title":"Int. Immunol."},{"key":"22230_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep12255","volume":"5","author":"SN Ganti","year":"2015","unstructured":"Ganti, S. N., Albershardt, T. C., Iritani, B. M. & Ruddell, A. Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth. Sci. Rep. 5, 12255 (2015).","journal-title":"Sci. Rep."},{"key":"22230_CR41","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen, P. et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366\u2013370 (2014).","journal-title":"Nature"},{"key":"22230_CR42","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/0092-8674(93)90644-6","volume":"73","author":"H Gu","year":"1993","unstructured":"Gu, H., Zou, Y. R. & Rajewsky, K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 73, 1155\u20131164 (1993).","journal-title":"Cell"},{"key":"22230_CR43","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.4049\/jimmunol.1700557","volume":"199","author":"L Radomir","year":"2017","unstructured":"Radomir, L. et al. T Cells regulate peripheral naive mature B cell survival by cell-cell contact mediated through SLAMF6 and SAP. J. Immunol. 199, 2745\u20132757 (2017).","journal-title":"J. Immunol."},{"key":"22230_CR44","first-page":"158","volume":"6","author":"N Wang","year":"2015","unstructured":"Wang, N. et al. Negative regulation of humoral immunity due to interplay between the SLAMF1, SLAMF5, and SLAMF6 receptors. Front. Immunol. 6, 158 (2015).","journal-title":"Front. Immunol."},{"key":"22230_CR45","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.4049\/jimmunol.0900185","volume":"183","author":"R Madan","year":"2009","unstructured":"Madan, R. et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183, 2312\u20132320 (2009).","journal-title":"J. Immunol."},{"key":"22230_CR46","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3389\/fimmu.2018.01636","volume":"9","author":"M Tarique","year":"2018","unstructured":"Tarique, M. et al. Interleukin-10 producing regulatory B cells transformed CD4(+)CD25(\u2212) into Tregs and enhanced regulatory T cells function in human leprosy. Front. Immunol. 9, 1636 (2018).","journal-title":"Front. Immunol."},{"key":"22230_CR47","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41590-018-0087-1","volume":"19","author":"WN Haining","year":"2018","unstructured":"Haining, W. N. & Weiss, S. A. c-Maf in CD4(+) T cells: it\u2019s all about context. Nat. Immunol. 19, 429\u2013431 (2018).","journal-title":"Nat. Immunol."},{"key":"22230_CR48","doi-asserted-by":"publisher","first-page":"e12701","DOI":"10.1111\/sji.12701","volume":"88","author":"M Liu","year":"2018","unstructured":"Liu, M. et al. Transcription factor c-Maf is essential for IL-10 gene expression in B cells. Scand. J. Immunol. 88, e12701 (2018).","journal-title":"Scand. J. Immunol."},{"key":"22230_CR49","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/ni.1912","volume":"11","author":"L Apetoh","year":"2010","unstructured":"Apetoh, L. et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854\u2013861 (2010).","journal-title":"Nat. Immunol."},{"key":"22230_CR50","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.celrep.2019.10.018","volume":"29","author":"CJM Piper","year":"2019","unstructured":"Piper, C. J. M. et al. Aryl hydrocarbon receptor contributes to the transcriptional program of IL-10-producing regulatory B cells. Cell Rep. 29, 1878\u20131892 e1877 (2019).","journal-title":"Cell Rep."},{"key":"22230_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13317-018-0109-x","volume":"9","author":"GK Vasileiadis","year":"2018","unstructured":"Vasileiadis, G. K. et al. Regulatory B and T lymphocytes in multiple sclerosis: friends or foes? Auto. Immun. Highlights 9, 9 (2018).","journal-title":"Auto. Immun. Highlights"},{"key":"22230_CR52","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2011.08.019","volume":"239","author":"S Knippenberg","year":"2011","unstructured":"Knippenberg, S. et al. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive\/memory Breg ratio during a relapse but not in remission. J. Neuroimmunol. 239, 80\u201386 (2011).","journal-title":"J. Neuroimmunol."},{"key":"22230_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/srep29699","volume":"6","author":"F Piancone","year":"2016","unstructured":"Piancone, F. et al. B lymphocytes in multiple sclerosis: Bregs and BTLA\/CD272 expressing-CD19+ lymphocytes modulate disease severity. Sci. Rep. 6, 29699 (2016).","journal-title":"Sci. Rep."},{"key":"22230_CR54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.coi.2019.07.007","volume":"61","author":"B Thi Cuc","year":"2019","unstructured":"Thi Cuc, B., Pohar, J. & Fillatreau, S. Understanding regulatory B cells in autoimmune diseases: the case of multiple sclerosis. Curr. Opin. Immunol. 61, 26\u201332 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"22230_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair, P. A. et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32, 129\u2013140 (2010).","journal-title":"Immunity"},{"key":"22230_CR56","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.4049\/jimmunol.1401329","volume":"194","author":"TF Tedder","year":"2015","unstructured":"Tedder, T. F. B10 cells: a functionally defined regulatory B cell subset. J. Immunol. 194, 1395\u20131401 (2015).","journal-title":"J. Immunol."},{"key":"22230_CR57","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI85113","volume":"127","author":"C Mauri","year":"2017","unstructured":"Mauri, C. & Menon, M. Human regulatory B cells in health and disease: therapeutic potential. J. Clin. Investig. 127, 772\u2013779 (2017).","journal-title":"J. Clin. Investig."},{"key":"22230_CR58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-1161-5_17","volume":"1190","author":"A Ray","year":"2014","unstructured":"Ray, A. & Basu, S. Regulatory B cells in experimental autoimmune encephalomyelitis (EAE). Methods Mol. Biol. 1190, 243\u2013255 (2014).","journal-title":"Methods Mol. Biol."},{"key":"22230_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jneuroim.2014.02.003","volume":"270","author":"C de Andres","year":"2014","unstructured":"de Andres, C. et al. New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids. J. Neuroimmunol. 270, 37\u201344 (2014).","journal-title":"J. Neuroimmunol."},{"key":"22230_CR60","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1172\/JCI68775","volume":"123","author":"T Kinnunen","year":"2013","unstructured":"Kinnunen, T. et al. Specific peripheral B cell tolerance defects in patients with multiple sclerosis. J. Clin. Investig. 123, 2737\u20132741 (2013).","journal-title":"J. Clin. Investig."},{"key":"22230_CR61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jaut.2017.10.011","volume":"88","author":"Y Okada","year":"2018","unstructured":"Okada, Y. et al. Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production. J. Autoimmun. 88, 103\u2013113 (2018).","journal-title":"J. Autoimmun."},{"key":"22230_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clim.2017.04.014","volume":"184","author":"E Staun-Ram","year":"2017","unstructured":"Staun-Ram, E. & Miller, A. Effector and regulatory B cells in multiple sclerosis. Clin. Immunol. 184, 11\u201325 (2017).","journal-title":"Clin. Immunol."},{"key":"22230_CR63","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2012.05.017","volume":"36","author":"F Zhao","year":"2012","unstructured":"Zhao, F., Cannons, J. L., Dutta, M., Griffiths, G. M. & Schwartzberg, P. L. Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis. Immunity 36, 1003\u20131016 (2012).","journal-title":"Immunity"},{"key":"22230_CR64","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1124\/jpet.106.103192","volume":"318","author":"R Aharoni","year":"2006","unstructured":"Aharoni, R. et al. Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease. J. Pharm. Exp. Ther. 318, 68\u201378 (2006).","journal-title":"J. Pharm. Exp. Ther."},{"key":"22230_CR65","doi-asserted-by":"publisher","unstructured":"LaFrance-Corey, R. G. & Howe, C. L. Isolation of brain-infiltrating leukocytes. J. Vis. Exp. https:\/\/doi.org\/10.3791\/2747 (2011).","DOI":"10.3791\/2747"},{"key":"22230_CR66","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/s41596-019-0164-4","volume":"14","author":"H Keren-Shaul","year":"2019","unstructured":"Keren-Shaul, H. et al. MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing. Nat. Protoc. 14, 1841\u20131862 (2019).","journal-title":"Nat. Protoc."},{"key":"22230_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"22230_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"22230_CR69","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/bioinformatics\/btn209","volume":"24","author":"K Strimmer","year":"2008","unstructured":"Strimmer, K. fdrtool: a versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics 24, 1461\u20131462 (2008).","journal-title":"Bioinformatics"},{"key":"22230_CR70","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-1-4939-1161-5_13","volume":"1190","author":"EC Rosser","year":"2014","unstructured":"Rosser, E. C. & Mauri, C. Regulatory B cells in experimental mouse models of arthritis. Methods Mol. Biol. 1190, 183\u2013194 (2014).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22230-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22230-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22230-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T11:18:33Z","timestamp":1669979913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-22230-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["22230"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-22230-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1893"}}